175 related articles for article (PubMed ID: 9988077)
1. Indium-111 pentetreotide scintigraphy of mesenchymal tumor with oncogenic osteomalacia.
Nguyen BD; Wang EA
Clin Nucl Med; 1999 Feb; 24(2):130-1. PubMed ID: 9988077
[No Abstract] [Full Text] [Related]
2. [Detection of the primary tumor site in tumor-induced osteomalacia by indium-111 octreotide scintigraphy: a case report].
Takahashi M; Toru S; Ota K; Izumiyama H; Yokota T; Mizusawa H
Rinsho Shinkeigaku; 2008 Feb; 48(2):120-4. PubMed ID: 18326305
[TBL] [Abstract][Full Text] [Related]
3. Octreotide scanning in the detection of a mesenchymal tumour in the pubic symphysis causing hypophosphataemic osteomalacia.
Moran M; Paul A
Int Orthop; 2002; 26(1):61-2. PubMed ID: 11954853
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic osteomalacia associated with mesenchymal tumour detected by indium-111 octreotide scintigraphy.
Rhee Y; Lee JD; Shin KH; Lee HC; Huh KB; Lim SK
Clin Endocrinol (Oxf); 2001 Apr; 54(4):551-4. PubMed ID: 11318793
[TBL] [Abstract][Full Text] [Related]
5. Clinical impact of somatostatin receptor scintigraphy in the management of tumor-induced osteomalacia.
Duet M; Kerkeni S; Sfar R; Bazille C; Lioté F; Orcel P
Clin Nucl Med; 2008 Nov; 33(11):752-6. PubMed ID: 18936605
[TBL] [Abstract][Full Text] [Related]
6. Occult phosphaturic mesenchymal tumor detected by Tc-99m sestamibi scan.
Siegel HJ; Rock MG
Clin Nucl Med; 2002 Aug; 27(8):608-9. PubMed ID: 12170016
[No Abstract] [Full Text] [Related]
7. Imaging of oncogenic osteomalacia.
Gershinsky M; Croitoru S; Dickstein G; Bardicef O; Gelman R; Barmeir E
Isr Med Assoc J; 2007 Jul; 9(7):566-7. PubMed ID: 17710796
[No Abstract] [Full Text] [Related]
8. Tumor-induced osteomalacia: a case report.
Romualdo-Silva DD; Silva BC; Caetano CV; Tibúrcio AM; Nunes MB; Chagas SA; Polito ET; Ferreira AR; Purisch S
Arq Bras Endocrinol Metabol; 2009 Apr; 53(3):378-82. PubMed ID: 19578602
[TBL] [Abstract][Full Text] [Related]
9. [Tumor-induced osteomalacia in a patient with a phosphaturic mesenchymal tumor revealing feature of an ossifying fasciitis of the left abdominal wall].
Oba K; Takei A; Natori S; Arai K; Nakanishi K; Oda Y
Nihon Naika Gakkai Zasshi; 2002 Jun; 91(6):1870-2. PubMed ID: 12170756
[No Abstract] [Full Text] [Related]
10. Localisation of mesenchymal tumours by somatostatin receptor imaging.
Jan de Beur SM; Streeten EA; Civelek AC; McCarthy EF; Uribe L; Marx SJ; Onobrakpeya O; Raisz LG; Watts NB; Sharon M; Levine MA
Lancet; 2002 Mar; 359(9308):761-3. PubMed ID: 11888589
[TBL] [Abstract][Full Text] [Related]
11. Giant cell tumour of soft tissue causing oncogenic osteomalacia: report demonstrating the use of octreotide scintigraphy in tumour localization.
Harish S; Jurriaans E; Jan E; Sur M; Colterjohn N
Clin Radiol; 2008 Jan; 63(1):101-7. PubMed ID: 18068797
[No Abstract] [Full Text] [Related]
12. Tumor-induced osteomalacia.
Kaul M; Silverberg M; Dicarlo EF; Schneider R; Bass AR; Erkan D
Clin Rheumatol; 2007 Sep; 26(9):1575-9. PubMed ID: 17225058
[TBL] [Abstract][Full Text] [Related]
13. Bone and In-111 octreotide imaging in oncogenic osteomalacia: a case report.
Garcia CA; Spencer RP
Clin Nucl Med; 2002 Aug; 27(8):582-3. PubMed ID: 12170004
[TBL] [Abstract][Full Text] [Related]
14. Pathologic quiz case. A 36-year-old woman with muscle pain and weakness. Phosphaturic mesenchymal tumor (mixed connective tissue variant)/oncogenic osteomalacia.
Reis-Filho JS; Paiva ME; Lopes JM
Arch Pathol Lab Med; 2002 Oct; 126(10):1245-6. PubMed ID: 12385334
[No Abstract] [Full Text] [Related]
15. Evaluation of tumor-induced osteomalacia with 111In-pentetreotide scintigraphy.
Palot Manzil FF; Bhambhvani PG; O'Malley JP
J Nucl Med Technol; 2013 Dec; 41(4):299-301. PubMed ID: 24159011
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic osteomalacia: two case reports with surprisingly different outcomes.
Seijas R; Ares O; Sierra J; Pérez-Dominguez M
Arch Orthop Trauma Surg; 2009 Apr; 129(4):533-9. PubMed ID: 19125258
[TBL] [Abstract][Full Text] [Related]
17. [Tumor-induced osteomalacia caused by a late-revealing phosphaturic mesenchymal tumor].
Chazal T; Khanine V; Lidove O; Godot S; Ziza JM
Rev Med Interne; 2017 Jun; 38(6):412-415. PubMed ID: 27659744
[TBL] [Abstract][Full Text] [Related]
18. [Hypophosphatemic osteomalacia associated phosphaturic mesenchymal tumor of bone: report of a case].
Gong LH; Sun XQ; Xi Y; Ding Y; Huang XY
Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):201-2. PubMed ID: 23769443
[No Abstract] [Full Text] [Related]
19. Tumor-induced osteomalacia: successful treatment by radio-guided tumor surgery.
Harbeck B; Schöcklmann H; Seekamp A; Czech N; Mönig H
J Clin Rheumatol; 2009 Feb; 15(1):31-4. PubMed ID: 19125132
[TBL] [Abstract][Full Text] [Related]
20. Positive somatostatin receptor imaging does not predict somatostatin analogue efficacy in tumor-induced osteomalacia.
Łebek-Szatańska A; Papierska L; Marcinowska-Suchowierska E; Nowak KM; Zgliczyński W; Misiorowski W
Pol Arch Intern Med; 2018 Sep; 128(9):554-555. PubMed ID: 30141426
[No Abstract] [Full Text] [Related]
[Next] [New Search]
